| Identification | Back Directory | [Name]
Benzenesulfonamide, N,N,2-trimethyl-5-[[4-[2-[4-[[(methylamino)carbonyl]amino]phenyl]-4-pyridinyl]-2-pyrimidinyl]amino]- | [CAS]
1402452-10-1 | [Synonyms]
hSMG-1 inhibitor 11e
Benzenesulfonamide, N,N,2-trimethyl-5-[[4-[2-[4-[[(methylamino)carbonyl]amino]phenyl]-4-pyridinyl]-2-pyrimidinyl]amino]- | [Molecular Formula]
C26H27N7O3S | [MOL File]
1402452-10-1.mol | [Molecular Weight]
517.6 |
| Chemical Properties | Back Directory | [storage temp. ]
4°C, away from moisture and light | [solubility ]
DMSO : 50 mg/mL (96.60 mM; Need ultrasonic) | [form ]
Solid | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Biological Activity]
HSMG-1 inhibitor 11e is a potent and selective hSMG-1 kinase inhibitor with IC50 value <0.05 nM. hSMG-1 inhibitor 11e exhibits 900-fold selectivity for hSMG-1 over mTOR (IC50 of 45 nM), PI3Kα/γ (IC50 of 61 nM and 92 nM) and CDK1/CDK2 (IC50 of 32 μM and 7.1 μM). | [in vitro]
HSMG-1 kinase plays a dual role in a highly conserved RNA surveillance pathway termed nonsense-mediated RNA decay (NMD) and in cellular genotoxic stress response. Since deregulation of cellular responses to stress contributes to tumor growth and resistance to chemotherapy, hSMG-1 is a potential target for cancer treatment. | [target]
| mTOR 45 nM (IC 50 ) | PI3Kα 61 nM (IC 50 ) | PI3Kγ 92 nM (IC 50 ) | CDK1 32 μM ( IC 50 ) | CDK2 7.1 μM (IC 50 ) | hSMG-1 <0.05 nM (IC 50 ) | | [storage]
4°C, away from moisture and light |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|